Skip to content

Treatment of stage I-III periodontitis
The EFP S3-level clinical practice guideline

     

    Treatment of stage I-III periodontitis
    The EFP S3-level clinical practice guideline

     

    Where does the need for this guideline come from?


    • Implementation of the new classification of periodontitis should facilitate
    the use of appropriate preventive and therapeutic interventions, depending
    on the stage and grade of the disease. The application of this S3-level clinical
    practice guideline will allow a homogeneous and evidence-based approach to
    the management of stage I–III periodontitis.
    What do patients need to know?
    • An essential prerequisite to therapy is to inform the patient of the diagnosis,
    including causes of the condition, risk factors, treatment alternatives and
    expected risks and benefits including explanations regarding consequences of
    refused treatment.
    • This discussion should be followed by agreement on a personalized care plan.
    • The plan might need to be modified during the treatment journey, depending
    on patient preferences, clinical findings and changes to overall health.

    How do we interpret these infographics?


    Blue colour:  Recommendations in favor of a particular
    strategy of treatment or specific procedure.

    Orange colour: Open recommendation in which the
    clinician is responsible for the final choice
    of a particular strategy of treatment or
    specific procedure based on specific patient
    characteristics.
    Uncertain recommendation for whose
    clarification further research is needed.
    Red colour: Recommendations against a particular
    strategy of treatment or specific procedure.


     

     

     

     

     

    Aim:
    · Controlling (reducing/eliminating) the subgingival biofilm and calculus (subgingival instrumentation) with
    possible removal of root surface (cementum).
    · Subgingival instrumentation may be supplemented with the following adjunctive interventions: physical
    or chemical agents, host-modulating agents (local or systemic), topical antimicrobials, subgingival locally
    delivered or systemic antimicrobials.
    · It should be implemented in all periodontitis patients, irrespective of the stage of their disease and it should be
    re-evaluated after an adequate healing period.

                

                       Subgingival instrumentation